Literature DB >> 21768521

Production of KPC-2 carbapenemase by an Escherichia coli clinical isolate belonging to the international ST131 clone.

Dearbháile Morris, Fiona Boyle, Catherine Ludden, Iris Condon, James Hale, Nuala O'Connell, Lorraine Power, Teck Wee Boo, Hiran Dhanji, Christian Lavallee, Neil Woodford, Martin Cormican.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21768521      PMCID： PMC3186997          DOI： 10.1128/AAC.05127-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  12 in total

Review 1.  Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae.

Authors:  Karen Bush
Journal:  Curr Opin Microbiol       Date:  2010-10-01       Impact factor: 7.934

2.  Global spread of New Delhi metallo-β-lactamase 1.

Authors:  Laurent Poirel; Cécile Hombrouck-Alet; Claire Freneaux; Sandrine Bernabeu; Patrice Nordmann
Journal:  Lancet Infect Dis       Date:  2010-12       Impact factor: 25.071

3.  Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center.

Authors:  Neil Woodford; Philip M Tierno; Katherine Young; Luke Tysall; Marie-France I Palepou; Elaina Ward; Ronald E Painter; Deborah F Suber; Daniel Shungu; Lynn L Silver; Kenneth Inglima; John Kornblum; David M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

4.  Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum (beta)-lactamases.

Authors:  Neil Woodford; Elizabeth J Fagan; Matthew J Ellington
Journal:  J Antimicrob Chemother       Date:  2005-11-10       Impact factor: 5.790

5.  Escherichia coli ST131 producing extended-spectrum β-lactamases plus VIM-1 carbapenemase: further narrowing of treatment options.

Authors:  Elisabetta Mantengoli; Francesco Luzzaro; Patrizia Pecile; Daniela Cecconi; Annalisa Cavallo; Letizia Attala; Alessandro Bartoloni; Gian Maria Rossolini
Journal:  Clin Infect Dis       Date:  2011-01-10       Impact factor: 9.079

Review 6.  Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain.

Authors:  Benjamin A Rogers; Hanna E Sidjabat; David L Paterson
Journal:  J Antimicrob Chemother       Date:  2010-11-16       Impact factor: 5.790

7.  An update of the evolving epidemic of blaKPC-2-carrying Klebsiella pneumoniae in Greece (2009-10).

Authors:  Panagiota Giakkoupi; Costas C Papagiannitsis; Vivi Miriagou; Olga Pappa; Michalis Polemis; Kyriaki Tryfinopoulou; Leonidas S Tzouvelekis; Alkiviadis C Vatopoulos
Journal:  J Antimicrob Chemother       Date:  2011-05-04       Impact factor: 5.790

8.  Complexity and diversity of Klebsiella pneumoniae strains with extended-spectrum beta-lactamases isolated in 1994 and 1996 at a teaching hospital in Durban, South Africa.

Authors:  S Y Essack; L M Hall; D G Pillay; M L McFadyen; D M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

9.  Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains.

Authors:  Olivier Clermont; Hiran Dhanji; Mathew Upton; Tarek Gibreel; Andrew Fox; David Boyd; Michael R Mulvey; Patrice Nordmann; Etienne Ruppé; Jean Louis Sarthou; Thierry Frank; Sophie Vimont; Guillaume Arlet; Catherine Branger; Neil Woodford; Erick Denamur
Journal:  J Antimicrob Chemother       Date:  2009-05-27       Impact factor: 5.790

10.  Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258.

Authors:  Brandon Kitchel; J Kamile Rasheed; Jean B Patel; Arjun Srinivasan; Shiri Navon-Venezia; Yehuda Carmeli; Alma Brolund; Christian G Giske
Journal:  Antimicrob Agents Chemother       Date:  2009-06-08       Impact factor: 5.191
View more
  22 in total

Review 1.  Mechanisms of resistance and clinical relevance of resistance to β-lactams, glycopeptides, and fluoroquinolones.

Authors:  Louis B Rice
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

2.  Detection of OXA-48 carbapenemase in the pandemic clone Escherichia coli O25b:H4-ST131 in the course of investigation of an outbreak of OXA-48-producing Klebsiella pneumoniae.

Authors:  Dearbháile Morris; Edel McGarry; Meaghan Cotter; Virginie Passet; Maureen Lynch; Catherine Ludden; Margaret M Hannan; Sylvain Brisse; Martin Cormican
Journal:  Antimicrob Agents Chemother       Date:  2012-05-07       Impact factor: 5.191

Review 3.  Escherichia coli ST131, an intriguing clonal group.

Authors:  Marie-Hélène Nicolas-Chanoine; Xavier Bertrand; Jean-Yves Madec
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

4.  Molecular epidemiology of KPC-producing Escherichia coli: occurrence of ST131-fimH30 subclone harboring pKpQIL-like IncFIIk plasmid.

Authors:  Jessica A O'Hara; Fupin Hu; Chulsoo Ahn; Jeremy Nelson; Jesabel I Rivera; Anthony W Pasculle; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2014-05-12       Impact factor: 5.191

5.  Emergence of KPC-2-producing Escherichia coli isolates in an urban river in Harbin, China.

Authors:  Guofeng Xu; Yue Jiang; Wei An; Hongdong Wang; Xiuying Zhang
Journal:  World J Microbiol Biotechnol       Date:  2015-07-07       Impact factor: 3.312

Review 6.  The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae.

Authors:  Amy J Mathers; Gisele Peirano; Johann D D Pitout
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

7.  Clonal composition and community clustering of drug-susceptible and -resistant Escherichia coli isolates from bloodstream infections.

Authors:  Sheila Adams-Sapper; Binh An Diep; Francoise Perdreau-Remington; Lee W Riley
Journal:  Antimicrob Agents Chemother       Date:  2012-11-12       Impact factor: 5.191

8.  Complete sequence of a KPC-producing IncN multidrug-resistant plasmid from an epidemic Escherichia coli sequence type 131 strain in China.

Authors:  Liang Chen; Hongyan Hu; Kalyan D Chavda; Shulong Zhao; Renkun Liu; Hui Liang; Wei Zhang; Xiumei Wang; Michael R Jacobs; Robert A Bonomo; Barry N Kreiswirth
Journal:  Antimicrob Agents Chemother       Date:  2014-01-06       Impact factor: 5.191

9.  Diagnostic potential of monoclonal antibodies specific to the unique O-antigen of multidrug-resistant epidemic Escherichia coli clone ST131-O25b:H4.

Authors:  Valéria Szijártó; Jolanta Lukasiewicz; Tomasz K Gozdziewicz; Zoltán Magyarics; Eszter Nagy; Gábor Nagy
Journal:  Clin Vaccine Immunol       Date:  2014-04-30

10.  Emergence of Escherichia coli sequence type 131 isolates producing KPC-2 carbapenemase in China.

Authors:  Jia Chang Cai; Rong Zhang; Yan Yan Hu; Hong Wei Zhou; Gong-Xiang Chen
Journal:  Antimicrob Agents Chemother       Date:  2013-12-09       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.